The Correlation Between Degeneration of Paraspinal Muscle and Outcome of Patients With Lumbar Spinal Stenosis

December 28, 2021 updated by: Peking University Third Hospital
The photographical and functional parameters of paravertebral muscle in patients with lumbar spinal stenosis will be measured to investigate the correlation between paravertebral muscle degeneration and symptoms and prognosis of patients.By measuring the parameters of paravertebral muscle with normal people, the differences between the patients and normal people will be compared to establish an appropriate paravertebral muscle evaluation method.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

It is a prospective observational study. This study will recruit 200 patients with lumbar spinal stenosis who will undertake posterior lumbar decompression and fusion surgery in our hospital.They all take preoperative lumbar mri examination and waist and back muscle strength test as well as recording their preoperative visual analogue scale,oswestry disability index, lumbar stiffness disability index score.All patients will receive a follow-up lasting for 1 year,and we will record patients outcomes,such as visual analogue scale,oswestry disability index and lumbar stiffness disability index score at each follow-up time. At the same time,we will recruit 100 healthy subjects without lumbar diseases or chronic lumbar pain. The difference of their age with patients was less than 5 years. Meanwhile, lumbar dorsal muscle strength test and lumbar mri examination were conducted, and visual analogue scale as well as oswestry disability index and lumbar stiffness disability index score was recorded in healthy subjects.

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100191
        • Recruiting
        • Peking University Third Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

200 patients with lumbar spinal stenosis and 100 healthy people

Description

Inclusion Criteria:

  • patients with lumbar spinal stenosis
  • age>45 years old
  • without other spinal disease
  • without history of former spinal surgery

Exclusion Criteria:

  • With neuromuscular diseases
  • With hip joint or knee joint disease
  • Acute or severe chronic back pain of spinal stenosis that could interfere with the evaluation of endurance
  • Other serious diseases impacting the evaluation of endurance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
patients
(1) age ≥ 45 years, (2) diagnosed LSS through a combination of clinical history, physical examination and radiological changes showing spinal canal stenosis on magnetic resonance imaging
observation the difference between two groups
healthy people
(1) age ≥ 45 years; (2) without chronic low back pain (LBP)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
cross-sectional area of paraspinal muscles
Time Frame: Baseline
the cross-sectional area of paraspinal muscles reflects the quantity of paraspinal muscles. Higher cross-sectional area of paraspinal muscles means larger paraspinal muscle.
Baseline
functional cross-sectional area of paraspinal muscles
Time Frame: Baseline
functional cross-sectional area of paraspinal muscles reflects the quality of paraspinal muscles. It means the lean paraspinal muscle.
Baseline
Performance time of paraspinal muscle endurance test
Time Frame: Baseine
Participants were asked to lie prone on a plinth and lift their sternum from the plinth, raising their upper body.While maintaining this position, participants were asked to keep their arms in line with the body axis and not in contact with the plinth. Task failure was determined by a drop in the angle of trunk of greater than 10°at any point. The time was recorded until task failure or until the maximum contraction duration was reached (300 s).
Baseine
lumbar stiffness disability index
Time Frame: the follow-up time of 3 months
The lumbar stiffness disability index ranges from 0 to 100. Higher scores mean a worse outcome
the follow-up time of 3 months
lumbar stiffness disability index
Time Frame: the follow-up time of 6 months
The lumbar stiffness disability index ranges from 0 to 100. Higher scores mean a worse outcome.
the follow-up time of 6 months
lumbar stiffness disability index
Time Frame: the follow-up time of 12 months
The lumbar stiffness disability index ranges from 0 to 100. Higher scores mean a worse outcome.
the follow-up time of 12 months
lumbar stiffness disability index
Time Frame: Baseline
The lumbar stiffness disability index ranges from 0 to 100. Higher scores mean a worse outcome.
Baseline
The Oswestry Disability Index
Time Frame: Baseline
The Oswestry Disability Index ranges from 0 to 100.Higher scores mean a worse outcome.
Baseline
The Oswestry Disability Index
Time Frame: the follow-up time of 3 months
The Oswestry Disability Index ranges from 0 to 100.Higher scores mean a worse outcome.
the follow-up time of 3 months
The Oswestry Disability Index
Time Frame: the follow-up time of 6 months
The Oswestry Disability Index ranges from 0 to 100.Higher scores mean a worse outcome.
the follow-up time of 6 months
The Oswestry Disability Index
Time Frame: the follow-up time of 12 months
The Oswestry Disability Index ranges from 0 to 100.Higher scores mean a worse outcome.
the follow-up time of 12 months
Visual Analog Score
Time Frame: Baseline
Visual Analog Score is used to evaluate pain,ranging from 0 to 10.Higher scores mean a worse outcome.
Baseline
Visual Analog Score
Time Frame: the follow-up time of 3 months
Visual Analog Score is used to evaluate pain,ranging from 0 to 10.Higher scores mean a worse outcome.
the follow-up time of 3 months
Visual Analog Score
Time Frame: the follow-up time of 6 months
Visual Analog Score is used to evaluate pain,ranging from 0 to 10.Higher scores mean a worse outcome.
the follow-up time of 6 months
Visual Analog Score
Time Frame: the follow-up time of 12 months
Visual Analog Score is used to evaluate pain,ranging from 0 to 10.Higher scores mean a worse outcome.
the follow-up time of 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: weishi li, department of orthopaedic, peking university third hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 12, 2020

Primary Completion (Anticipated)

October 12, 2023

Study Completion (Anticipated)

January 21, 2024

Study Registration Dates

First Submitted

June 28, 2020

First Submitted That Met QC Criteria

December 25, 2020

First Posted (Actual)

December 30, 2020

Study Record Updates

Last Update Posted (Actual)

January 14, 2022

Last Update Submitted That Met QC Criteria

December 28, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lumbar Spinal Stenosis

Clinical Trials on observation

Subscribe